- Home
- ATOS vs SSTI Comparison
ATOS vs SSTI Comparison
Compare ATOS & SSTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- SSTI
- Stock Information
- Founded
- ATOS 2009
- SSTI 1996
- Country
- ATOS United States
- SSTI United States
- Employees
- ATOS N/A
- SSTI N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- SSTI Computer Software: Prepackaged Software
- Sector
- ATOS Health Care
- SSTI Technology
- Exchange
- ATOS Nasdaq
- SSTI Nasdaq
- Market Cap
- ATOS 174.8M
- SSTI 161.8M
- IPO Year
- ATOS 2012
- SSTI 2017
- Fundamental
- Price
- ATOS $1.54
- SSTI $12.37
- Analyst Decision
- ATOS Strong Buy
- SSTI Buy
- Analyst Count
- ATOS 3
- SSTI 6
- Target Price
- ATOS $6.25
- SSTI $22.70
- AVG Volume (30 Days)
- ATOS 502.2K
- SSTI 58.0K
- Earning Date
- ATOS 11-19-2024
- SSTI 11-12-2024
- Dividend Yield
- ATOS N/A
- SSTI N/A
- EPS Growth
- ATOS N/A
- SSTI N/A
- EPS
- ATOS N/A
- SSTI N/A
- Revenue
- ATOS N/A
- SSTI $102,392,000.00
- Revenue This Year
- ATOS N/A
- SSTI $15.81
- Revenue Next Year
- ATOS N/A
- SSTI $5.99
- P/E Ratio
- ATOS N/A
- SSTI N/A
- Revenue Growth
- ATOS N/A
- SSTI 24.16
- 52 Week Low
- ATOS $0.62
- SSTI $9.33
- 52 Week High
- ATOS $2.31
- SSTI $26.92
- Technical
- Relative Strength Index (RSI)
- ATOS 65.98
- SSTI 63.29
- Support Level
- ATOS $1.36
- SSTI $9.33
- Resistance Level
- ATOS $1.66
- SSTI $11.79
- Average True Range (ATR)
- ATOS 0.07
- SSTI 0.58
- MACD
- ATOS 0.02
- SSTI 0.26
- Stochastic Oscillator
- ATOS 80.65
- SSTI 100.00
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About SSTI SoundThinking Inc.
SoundThinking Inc is a public safety technology company that combines transformative solutions and strategic advisory services for law enforcement and civic leadership. Its flagship SafetySmart platform includes ShotSpotter, the acoustic gunshot detection system, CrimeTracer, the foremost law enforcement search engine, CaseBuilder, a one-stop investigation management system, and ResourceRouter, software that directs patrol and community anti-violence resources to help maximize their impact.